Breakingviews: Apple and Tesla?

Elon Musk's electric-car maker needs money as Tim Cook's cash-rich company angles its way in to autos. Breakingviews columnists debate the merits of Apple buying a stake in Tesla.

Read more

Breakingviews: Laboratory conditions

Robert Cyran tells Richard Beales why Abbott Labs' $4.3 bln asset sale to J&J eases pressure on the two tricky acquisitions totaling over $30 bln that it has in the pipeline.

Read more

Breakingviews: Deutsche's turn

Richard Beales and Antony Currie look at U.S. enforcers' demand that Deutsche Bank pays $14 billion in fines and the implications of even a lower final figure for the lender.

Read more

Breakingviews: Betting on Macau

Casino magnate Sheldon Adelson reckons the Chinese gambling enclave has hit bottom as he opens his latest resort there. Pete Sweeney and Jeffrey Goldfarb discuss why the odds may be long.

Read more

Breakingviews: Elon Musk's M&A woes

Antony Currie and Richard Beales explain that rising concerns about cash burn at both Tesla and SolarCity are making shareholders increasingly skeptical that the two companies will merge.

Read more

Breakingviews: Wells Fargo's swindle

The California bank's opening of fake customer accounts may not have racked up big fines but may be the most widespread of banking scandals yet, Breakingviews columnists discuss.

Read more

Breakingviews: Merger of equals signs

A $36 bln Canadian fertilizer deal has the hallmarks of a rare true merger while a $60 bln cross-border gas combo fell short. Richard Beales and Jeffrey Goldfarb discuss.

Read more

Breakingviews: Deportation economics

Gina Chon and Rob Cox discuss how the costs of Donald Trump's promise to deport 11 million undocumented immigrants outweigh the benefits.

Read more

Breakingviews: Apple seeds future

The new iPhone 7 gets rid of the headphone jack but more importantly adds new photo and video capabilities. Rob Cyran and Jeffrey Goldfarb break down the sales outlook.

Read more

Breakingviews: Un-mergers

Breakingviews editors discuss the record M&A activity in 2015 and why outstanding deals that may not close could make it close to a record year for failed mergers, too.

Read more

Breakingviews: Murdoch's settlements

Jen Saba and Rob Cox discuss how the high-profile harassment cases against Fox News and its former chief highlight poor oversight of the controlled media group.

Read more

Breakingviews: Drugmakers' D.C. dealing

As Congress prods Mylan over EpiPen in the latest probe on prescription prices, the pharmaceutical industry's massive lobbying spend gets put to the test. Gina Chon and Jeffrey Goldfarb discuss.

Read more

Breakingviews: Elon Musk's math

A $400 mln error was spotted by Lazard in a SolarCity valuation linked to its agreed sale to Tesla. Breakingviews editors break down this latest spreadsheet fail.

Read more

Breakingviews: Brazil after Rousseff

Antony Currie and Martin Langfield lay out how new President Michel Temer can help turn around the economy after his predecessor's impeachment – and how lawmakers could be a big impediment.

Read more